Datamonitor is an international company providing market intelligence, data analysis and opinion via a worldwide network of in-house analysts. Datamonitor is a division of Informa plc, a United Kingdom-based publisher and conference company.
The company has released a new report, “Celltrion: Biosimilars Company Analysis” last month.
This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s biosimilars portfolio, including analysis of key product profiles, examining key drivers and resistors to development, market sizing, specifics of development such as clinical trials for each key biosimilar molecule in development.
The company is thought to be responsible for filing the first biosimilar monoclonal antibody for approval in Europe. In 2009, Celltrion signed an agreement to manufacture and co-market eight biosimilars with Hospira in the US, EU and other key markets. And recently the company got the approval for the world’s first biosimilar monoclonal antibody in its homeland, South Korea.
If you want to buy the report, you can check the table of contents and rates from here:
Source: Wikipedia, Fast Market Research